Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation
NCT07613970
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT Number: NCT07594938
The goal of this observational study is to learn how neuromuscular fatigue develops after stroke and how changes in brain activity, muscle activity, and their interaction contribute to reduced motor performance in stroke survivors compared to healthy individuals. The study will include adults with a first-ever stroke in the subacute phase and age-matched healthy volunteers.
The main questions it aims to answer are:
* How does neuromuscular fatigue develop during repeated muscle contractions after stroke compared to healthy individuals? * How do brain activity, muscle activity, and brain-muscle interaction change during fatigue after stroke?
Researchers will compare stroke participants and healthy control participants to determine whether fatigue-related changes are more strongly associated with altered brain activity, altered muscle activity, or disrupted brain-muscle communication after stroke.
Participants will:
* Perform repeated leg muscle contractions until fatigue while seated in an experimental setup * Wear non-invasive sensors to record brain activity (EEG) and muscle activity (EMG) during the task * Complete the study during a single experimental session in which fatigue-related changes will be measured throughout the task
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Stroke is a leading cause of long-term disability worldwide. Although many stroke survivors can initiate movement, sustaining motor performance during everyday activities often becomes progressively difficult, suggesting abnormal development of neuromuscular fatigue. Neuromuscular fatigue, defined as an exercise-induced reduction in force-generating capacity, arises through interactions between central neural and peripheral muscular mechanisms. However, despite extensive investigation in healthy populations, the neurophysiological mechanisms underlying neuromuscular fatigue after stroke remain poorly understood. Existing studies have focused predominantly on peripheral manifestations of fatigue, with limited investigation of cortical oscillatory dynamics and brain-muscle communication. Here, we propose a multimodal neurophysiological study combining electroencephalography (EEG), electromyography (EMG), and corticomuscular coherence analyses to determine whether fatigability after stroke is driven predominantly by altered central neural processes rather than peripheral muscle failure. Stroke survivors and age-matched healthy controls will perform sustained isometric contractions while neural and muscular activity are recorded across progressive fatigue stages. We hypothesize that stroke survivors will exhibit earlier and greater fatigability, accompanied by altered cortical oscillatory activity, peripheral muscular changes, and disrupted corticomuscular coherence, consistent with a predominant contribution of central oscillatory dysfunction.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Stroke survivors will be recruited from Brussels University Hospital (Brussels, Belgium). Patients who have a first-ever stroke, ≥18 years, subacute phase: 1 week to 6 months post-stroke, quadriceps (hemiplegic side) strength ≤3/5 (Medical Research Council (MRC)), and Montreal Cognitive Assessment (MoCA) ≥21 will be included.
Exclusion criteria
Exclusion criteria
include a history of a previous stroke, severe spasticity (Modified Ashworth Scale (MAS) 3-4 in quadriceps/hamstrings), other neurological, motor, musculoskeletal, or orthopedic conditions affecting trunk stability and lower limb mobility, non-cerebral strokes (e.g., brainstem, cerebellar), or dementia (MoCA ≤20), and current or former athletes. Athletes are defined as individuals who participated in organized competitive sports and engaged in structured training ≥3 sessions per week for ≥1 year within the 5 years preceding stroke. Control participants will be excluded if they meet the same exclusion criteria.
Time frame: Outcome measure will be recorded at baseline and throughout the fatiguing contractions in the single experimental session (up to 40 minutes) and compared over 4 fatigue phases.
Fatigue-related changes in sensorimotor cortical activity will be assessed using EEG-derived absolute and relative spectral power in the mu (8-12 Hz), beta (13-30/35 Hz), and gamma (30/35-100 Hz) frequency bands, as well as changes in event-related desynchronization/event-related synchronization (ERD/ERS) magnitude over time. Measurements will be obtained at pre-fatigue baseline and continuously during the fatiguing task, with data segmented into contraction epochs and grouped into four fatigue phases for analysis.
Time frame: Outcome measure will be recorded throughout the fatiguing contractions in the single experimental session (up to 40 minutes) and compared over 4 fatigue phases.
Peripheral manifestations of fatigue will be assessed using shifts in EMG median frequency during repeated contractions. Data will be recorded continuously during the task and analyzed across contraction epochs grouped into four fatigue phases.
Time frame: Outcome measure will be recorded throughout the fatiguing contractions in the single experimental session (up to 40 minutes) and compared over 4 fatigue phases.
The interaction between cortical and muscular activity will be assessed using CMC, which quantifies synchronization between EEG and EMG signals. Corticomuscular coherence will be assessed from simultaneous EEG and EMG recordings during repeated contractions and analyzed across contraction epochs grouped into four fatigue phases.
Vrije Universiteit Brussel
Other
Exploring Neuromuscular Fatigue in Stroke Survivors: Understanding Central-Peripheral Interaction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07613970
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT07237048
Brain Diseases, Cardiovascular Diseases
Brooklyn, New York, United States
View Trial DetailsNCT07553650
Brain Diseases, Brain Infarction
Hamburg, Free and Hanseatic City of Hamburg, Germany
View Trial DetailsNCT07639632
Brain Diseases, Cardiovascular Diseases
Houston, Texas, United States
View Trial Details